Edit Symbol List
Don't know the stock symbol? Use the
Symbol Lookup tool.
Alphabetize the sort order of my symbols
Investing just got easier…
ETFs with ICPT as a Top 10 Holding*
|Weighting||ETF Name (Symbol)||100-Day Price Change (%)|
|4.41%||First Trust Amex Biotech Index Fund (FBT)||+25.88 (28.67%)|
|1.62%||SPDR Series Trust SPDR S&P Biotech ETF (XBI)||+62.06 (39.83%)|
|0%||BioShares Biotechnology Clinical Trials Fund (BBC)||N/A (N/A)|
Company Description (as filed with the SEC)
We are a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat chronic liver and intestinal diseases utilizing our proprietary bile acid chemistry. Our product candidates have the potential to treat orphan and more prevalent diseases for which there currently are limited therapeutic solutions. Our lead product candidate, obeticholic acid, or OCA, is a bile acid analog, a chemical substance that has a structure based on a naturally occurring human bile acid. OCA is a first-in-class product candidate that selectively binds to and induces activity in the farnesoid X receptor, or FXR, which we believe has broad liver-protective properties. We are developing OCA initially for primary biliary cirrhosis, or PBC, as a second line treatment for patients who have an inadequate response to or who are unable to tolerate standard of care therapy and therefore need additional treatment. ... More ...
Where does ICPT fit in the risk graph?
|Annual EPS Est:||$-2.18|
|Quarterly EPS Est:||-1.53|